Evidence of KA21.pdf
Transcript of Evidence of KA21.pdf
-
8/17/2019 Evidence of KA21.pdf
1/36
Evidence of KA21
-
8/17/2019 Evidence of KA21.pdf
2/36
Antitumor beta glucan from the cultured fruit body of Agaric
http://www.ncbi.nlm.nih.gov/pubmed/11456124
http://www.ncbi.nlm.nih.gov/pubmed/11456124http://www.ncbi.nlm.nih.gov/pubmed/11456124
-
8/17/2019 Evidence of KA21.pdf
3/36
Antitumor activity
-
8/17/2019 Evidence of KA21.pdf
4/36
Ipomoea batatas and Agarics blazei ameliorate diabetic disordtherapeutic antioxidant potential in streptozotocin-induced drats.
http://www.ncbi.nlm.nih.gov/pubmed/21562638
http://www.ncbi.nlm.nih.gov/pubmed/21562638http://www.ncbi.nlm.nih.gov/pubmed/21562638
-
8/17/2019 Evidence of KA21.pdf
5/36
Diabetes
Blood sugar
normal
control
Ipomoea bata
Kingagaricus
Week
-
8/17/2019 Evidence of KA21.pdf
6/36
Immunomodulating Activity of Agaricus brasiliensis KA21 in MHuman Volunteers.
http://www.ncbi.nlm.nih.gov/pubmed/18604247
http://www.ncbi.nlm.nih.gov/pubmed/18604247http://www.ncbi.nlm.nih.gov/pubmed/18604247
-
8/17/2019 Evidence of KA21.pdf
7/36
Biochemical
parameters
Before (mean ± SD) After (mean ± SD) Statistics ( P -valu
Total protein (g dl – 1) 7.50 ± 0.16 7.41 ± 0.25 0.31
BUN (mg dl – 1) 15.81± 5.93 13.45± 2.25 0.12
Creatinine (mg dl – 1) 0.92 ± 0.21 0.90 ± 0.20 0.19
GOT (µ l – 1) 18.8 ± 4.75 19.8 ± 4.40 0.10
GPT (µ l – 1) 15.7 ± 6.90 16.3 ± 4.90 0.52
-GTP (µ l – 1) 35.4 ± 29.6GTP 35.9 ± 30.1 0.89
(N = 11).
Table 3. Safety of A. brasi l iensis KA21 in human volunteers
Kingagaricus100 9g a day was administrated for 6 months to 11 subjects
Safety data
-
8/17/2019 Evidence of KA21.pdf
8/36
Copyright restrictions may apply.
Liu, Y. et al. eCAM 2007 0:nem016v1-15; doi:10.1093/ecam/nem016
Effect of A. brasiliensis on body weight
The normal dose was administrated to 12 subjects for 3 months
-
8/17/2019 Evidence of KA21.pdf
9/36
Copyright restrictions may apply.
Liu, Y. et al. eCAM 2007 0:nem016v1-15; doi:10.1093/ecam/nem016
Effect of A. brasiliensis on BMI
The normal dose was administrated to 12 subjects for 3 months
-
8/17/2019 Evidence of KA21.pdf
10/36
Copyright restrictions may apply.
Liu, Y. et al. eCAM 2007 0:nem016v1-15; doi:10.1093/ecam/nem016
Effect of A. brasiliensis on percentage body fat
The normal dose was administrated to 12 subjects for 3 months
-
8/17/2019 Evidence of KA21.pdf
11/36
Copyright restrictions may apply.
Liu, Y. et al. eCAM 2007 0:nem016v1-15; doi:10.1093/ecam/nem016
Effect of A. brasiliensis on percentage visceral fat
The normal dose was administrated to 12 subjects for 3 months
-
8/17/2019 Evidence of KA21.pdf
12/36
Copyright restrictions may apply.
Liu, Y. et al. eCAM 2007 0:nem016v1-15; doi:10.1093/ecam/nem016
Effect of A. brasiliensis on blood glucose level
The normal dose was administrated to 12 subjects for 3 months
-
8/17/2019 Evidence of KA21.pdf
13/36
Copyright restrictions may apply.
Liu, Y. et al. eCAM 2007 0:nem016v1-15; doi:10.1093/ecam/nem016
Effect of A. brasiliensis on blood cholesterol level from the viewpoint of Mibyou
-
8/17/2019 Evidence of KA21.pdf
14/36
Copyright restrictions may apply.
Liu, Y. et al. eCAM 2007 0:nem016v1-15; doi:10.1093/ecam/nem016
Effect of A. brasiliensis on neutral fat level from the viewpoint of Mibyou
-
8/17/2019 Evidence of KA21.pdf
15/36
Copyright restrictions may apply.
Liu, Y. et al. eCAM 2007 0:nem016v1-15; doi:10.1093/ecam/nem016
Comparison of NK cell activity before and after administration of A. brasiliensis
The normal dose or placebo was administrated to 8 subjects for 7 days (
-
8/17/2019 Evidence of KA21.pdf
16/36
Copyright restrictions may apply.
Liu, Y. et al. eCAM 2007 0:nem016v1-15; doi:10.1093/ecam/nem016
Comparison of NK cell activity before and after administration of placebo
The normal dose or placebo was administrated to 8 subjects for 7 days (
-
8/17/2019 Evidence of KA21.pdf
17/36
Agaricus brasiliensis KA21 improves circulatory functions inspontaneously hypertensive rats.
http://www.ncbi.nlm.nih.gov/pubmed/24433071
http://www.ncbi.nlm.nih.gov/pubmed/24433071http://www.ncbi.nlm.nih.gov/pubmed/24433071
-
8/17/2019 Evidence of KA21.pdf
18/36
Improve Circulatory Function (SHR)
-
8/17/2019 Evidence of KA21.pdf
19/36
Diet
-
8/17/2019 Evidence of KA21.pdf
20/36
Neutral Fat (Triglyceride)
-
8/17/2019 Evidence of KA21.pdf
21/36
Protect Heart FunctionCentral Nerve system
He
Muscle
-
8/17/2019 Evidence of KA21.pdf
22/36
Differences in antioxidant activities of outdoor- and indoor-cuAgaricus brasiliensis, and protective effects against carbontetrachloride-induced acute hepatic injury in mice.
http://www.ncbi.nlm.nih.gov/pubmed/25418207
http://www.ncbi.nlm.nih.gov/pubmed/25418207http://www.ncbi.nlm.nih.gov/pubmed/25418207
-
8/17/2019 Evidence of KA21.pdf
23/36
Antioxidant activity
Kingagaricus Green house
-
8/17/2019 Evidence of KA21.pdf
24/36
Liver Protection
Normal
Kingagaricus 3%
Green house agaricus 3%
10
-
8/17/2019 Evidence of KA21.pdf
25/36
Liver Protection
Normal
Kingagaricus 10%
24hours
-
8/17/2019 Evidence of KA21.pdf
26/36
Open-Label Study of the Influence of Food Containing the RoyMushroom, Agaricus brasiliensis KA21 (Higher BasidiomyceteQuality of Life of Healthy Human Volunteers.
http://www.ncbi.nlm.nih.gov/pubmed/26756293
http://www.ncbi.nlm.nih.gov/pubmed/26756293http://www.ncbi.nlm.nih.gov/pubmed/26756293
-
8/17/2019 Evidence of KA21.pdf
27/36
QOL
2.0
2.2
2.4
2.6
2.8
3.0
3.2
3.4
3.6
3.8
4.0
Pre-intake 6th week 12th week
Fatigue
L H
2.0
2.2
2.4
2.6
2.8
3.0
3.2
3.4
3.6
3.8
4.0
Pre-intake 6th week 12th week
Hair Loss
L H
2.0
2.2
2.4
2.6
2.8
3.0
3.2
3.4
3.6
3.84.0
Pre-intake 6th w
Grey H
L
900mg or 1500mg
-
8/17/2019 Evidence of KA21.pdf
28/36
-
8/17/2019 Evidence of KA21.pdf
29/36
QOL
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
Pre-intake 6th week 12th week
difficulty staying awake during the day
L H
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
Pre-intake 6th week
ease of getting out of bed
L H
-
8/17/2019 Evidence of KA21.pdf
30/36
Not published data
IGF 1
-
8/17/2019 Evidence of KA21.pdf
31/36
IGF-1
IGF-1 level High
Low
Peak
Aging
-
8/17/2019 Evidence of KA21.pdf
32/36
IGF-1
• Anti-Aging effects
Hair regrowth
Improve immunity
Better skin condition, less spots, wrinkles
Improve cognitive function
Improve metabolic syndrome
Generative function
-
8/17/2019 Evidence of KA21.pdf
33/36
IGF-1
This is not K
Anti-Aging
-
8/17/2019 Evidence of KA21.pdf
34/36
0
50
100
150
200
Control(n=5)
Agalicus blazei(water extract) (10 mg/kg/day,
po)(n=5)
*, p
-
8/17/2019 Evidence of KA21.pdf
35/36
IGF-1
2 months
Dog took Kingagaricus100 for 2 months
-
8/17/2019 Evidence of KA21.pdf
36/36
Reduce side effect from anti cancer dru
Number of Leucocyte
Control
cyclophosphamide; CPA
cyclophosphamide; CPA+agaricus hot
cyclophosphamide; CPA+agaricus cold